VCP Scanner
Stock Screener
Filter stocks with fundamental & technical criteria
Market Themes
Curated industry baskets & thematic leaders
Earnings Hub
Calendar, EPS surprise stats & earnings transcripts
Market News
Real-time market intelligence & AI overviews
Insider Buying
SEC Form 4 corporate insider purchases
MinerviniVCP SetupsTrend Template
O'NeilCup with HandleFlat BaseDouble BottomCANSLIM Leaders
QullamaggieHigh Tight FlagsFlag BreakoutsEpisodic PivotsMomentum Leaders
KellWedge PopEMA Crossback
LivermorePivotal Points
PatternsFalling Wedge & ChannelBase Breakouts
View All Playbooks...
BreakoutsScanner
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Index & ETFs
SPY vs QQQVTI vs VOOSPY vs IWM
Compare Any Stocks...
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
VisualizeInteractive multi-year financial charts
Watchlist
BreakoutsScanner
WatchlistPricing
Ctrl K
Pricing
G
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Analyze deeply. Research with clarity.

Data updated daily

Product

  • Screener
  • Scanner
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • Pricing
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly market insights — free

© 2026 VCP Scanner
AboutPrivacyTermsRefund Policy
Not financial advice. Do your own research.
ScreenerBreakoutsScannerWatchlist
GGenpact Limited
$42.27$7.2B
Overview & Tools
OverviewChart Terminal ↗Visualize
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice History
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Discovery & Screens
Live BreakoutsStock ScreenerOwnership
HomeStocksGFinancials

Genpact Limited (G) Income Statement

21Y historyFree accessUpdated daily

Revenue growth accelerated to 7.1% in Q2 2026 with gross margin expanding to 36.5%, though SG&A rose 10.4% year-over-year, tempering operating leverage.

Income StatementBalance SheetCash FlowRatios

G Income Statement

Annual statement

G Income Statement

Genpact Limited (G) annual income statement — 21-year revenue, gross profit & net income history

AnnualQuarterly
MetricTTMDec'25Dec'24Dec'23Dec'22Dec'21Dec'20Dec'19Dec'18Dec'17Dec'16Dec'15Dec'14Dec'13Dec'12Dec'11Dec'10Dec'09Dec'08Dec'07Dec'06Dec'05
Sales/Revenue5.34B5.08B4.77B4.48B4.37B4.02B3.71B3.52B3B2.74B2.57B2.46B2.28B2.13B1.9B1.6B1.26B1.12B1.04B822.68M613.05M491.89M
Revenue Growth %6.69%6.56%6.48%2.42%8.68%8.43%5.36%17.32%9.64%6.46%4.46%7.97%6.92%12.09%18.84%27.12%12.4%7.61%26.52%34.2%24.63%-
Cost of Goods Sold3.37B3.27B3.08B2.91B2.83B2.59B2.42B2.29B1.92B1.68B1.55B1.49B1.38B1.32B1.16B1B788.52M672.62M619.23M515.46M360.88M303.96M
COGS % of Revenue-64.43%64.55%64.92%64.85%64.4%65.19%65.18%64.04%61.44%60.46%60.69%60.46%61.89%60.87%62.79%62.63%60.05%59.49%62.66%58.87%61.79%
Gross Profit1.98B1.81B1.69B1.57B1.54B1.43B1.29B1.23B1.08B1.06B1.02B967.5M901.35M812.43M744.21M595.54M470.44M447.45M421.62M307.22M252.17M187.93M
Gross Margin %37%35.57%35.45%35.08%35.15%35.6%34.81%34.82%35.96%38.56%39.54%39.31%39.54%38.11%39.13%37.21%37.37%39.95%40.51%37.34%41.13%38.21%
Gross Profit Growth %-6.9%7.6%2.23%7.29%10.9%5.33%13.61%2.23%3.84%5.06%7.34%10.95%9.17%24.96%26.59%5.14%6.13%37.24%21.83%34.18%-
Operating Expenses1.17B1.05B988M939.81M1.03B922.96M852.52M796.48M730.87M724.21M675.21M633.3M607.32M502.9M479.86M379.29M292.58M285.27M287.9M220.42M209.01M171.08M
OpEx % of Revenue-20.61%20.73%20.99%23.66%22.95%22.98%22.62%24.36%26.46%26.27%25.73%26.64%23.59%25.23%23.7%23.24%25.47%27.66%26.79%34.09%34.78%
Selling, General & Admin1.15B1.05B967.14M913.06M938.38M865.72M789.85M794.9M693.87M679.63M643.95M599.13M577.05M476.37M447.76M349.38M272.21M265.39M254.53M231.32M152.4M113.92M
SG&A % of Revenue-20.61%20.29%20.39%21.47%21.52%21.29%22.58%23.12%24.83%25.05%24.34%25.32%22.34%23.54%21.83%21.62%23.69%24.45%28.12%24.86%23.16%
Research & Development0000000000000000000000
R&D % of Revenue----------------------
Other Operating Expenses3M020.86M26.75M95.86M57.24M62.67M1.58M37.01M44.58M31.26M34.17M30.27M26.53M32.1M29.91M20.36M19.88M33.37M-10.9M56.61M57.16M
Operating Income810.96M760.01M702.06M630.86M502.15M509M438.72M429.38M348.15M331.28M341.21M334.19M294.03M309.53M264.35M216.24M177.86M162.18M133.71M86.8M43.16M16.85M
Operating Margin %15.17%14.96%14.73%14.09%11.49%12.65%11.83%12.2%11.6%12.1%13.27%13.58%12.9%14.52%13.9%13.51%14.13%14.48%12.85%10.55%7.04%3.43%
Operating Income Growth %-8.25%11.29%25.63%-1.35%16.02%2.18%23.33%5.09%-2.91%2.1%13.66%-5.01%17.09%22.24%21.58%9.67%21.29%54.04%101.14%156.08%-
EBITDA918.37M854.97M771.84M734.85M631.67M676.57M598.56M558.09M451.87M426.19M422.94M416.99M373.64M385.99M343.74M294.73M252.02M241.77M225.78M173.13M121.15M96.68M
EBITDA Margin %17.18%16.83%16.19%16.41%14.45%16.82%16.14%15.85%15.06%15.57%16.45%16.94%16.39%18.1%18.07%18.42%20.02%21.58%21.69%21.04%19.76%19.66%
EBITDA Growth %10.32%10.77%5.03%16.34%-6.64%13.03%7.25%23.51%6.02%0.77%1.43%11.6%-3.2%12.29%16.63%16.95%4.24%7.08%30.41%42.91%25.3%-
D&A (Non-Cash Add-back)107.41M94.96M69.78M103.99M129.52M167.57M159.84M128.71M103.72M94.92M81.74M82.8M79.61M76.46M79.39M78.49M74.16M79.59M92.07M86.33M77.99M79.83M
EBIT786.91M779.74M756.33M668.53M523.34M541.44M456.72M450.2M410.53M360.5M353.08M331.58M283.39M341.87M291.13M270.94M185.96M164.76M151.89M86.8M47.35M21.3M
Net Interest Income-54.63M-49.6M-47.21M-47.94M-52.2M-51.43M-48.96M-43.46M-37.12M-31.73M-16.18M-21.15M-29.39M-19.98M-16.11M5.92M2.86M3.11M6.43M-7.54M-11.95M-8.89M
Interest Income22.89M23.92M32.29M18.37M5.9M6.88M7.28M7.32M11.39M8.18M7.25M8.68M4.41M15.74M12.01M15.14M5.59M7.45M14.89M6.58M1.48M1.7M
Interest Expense77.52M73.52M79.51M66.31M58.1M58.31M56.24M50.78M48.51M39.92M23.43M29.83M33.8M35.72M28.12M9.21M2.73M4.33M8.46M14.11M13.43M10.59M
Other Income/Expense-40.79M-29.86M-25.24M-28.63M-36.91M-25.87M-38.24M-29.96M13.87M-10.7M-11.56M-32.44M-44.44M-3.38M-1.34M45.49M5.37M-1.76M9.71M-5.45M-9.23M-6.15M
Pretax Income770.16M730.15M676.82M602.22M465.24M483.13M400.48M399.42M362.02M320.58M329.64M301.75M249.59M306.15M263.01M261.73M183.23M160.42M134.89M81.35M33.92M10.71M
Pretax Margin %14.41%14.37%14.2%13.45%10.64%12.01%10.8%11.35%12.06%11.71%12.82%12.26%10.95%14.36%13.83%16.35%14.55%14.32%12.96%9.89%5.53%2.18%
Income Tax181.68M177.65M163.15M-29.03M111.83M113.68M92.2M94.54M80.76M59.74M62.1M61.94M57.42M71.1M78.42M70.66M34.2M25.47M8.82M16.54M-5.85M-6.4M
Effective Tax Rate %23.59%24.33%24.11%-4.82%24.04%23.53%23.02%23.67%22.31%18.64%18.84%20.53%23.01%23.22%29.82%27%18.67%15.87%6.54%20.33%-17.25%-59.75%
Net Income588.48M552.49M513.67M631.25M353.4M369.45M308.28M304.88M281.26M260.84M267.55M239.82M192.17M235.05M184.59M184.29M142.18M127.3M125.14M56.42M39.77M17.1M
Net Margin %11.01%10.88%10.78%14.1%8.08%9.19%8.31%8.66%9.37%9.53%10.41%9.74%8.43%11.02%9.71%11.52%11.29%11.37%12.02%6.86%6.49%3.48%
Net Income Growth %6.74%7.56%-18.63%78.62%-4.34%19.84%1.11%8.4%7.83%-2.51%11.56%24.79%-18.24%27.34%0.16%29.62%11.69%1.73%121.79%41.87%132.53%-
Net Income (Continuing)588.48M552.49M513.67M631.25M353.4M369.45M308.28M304.88M281.26M260.84M267.55M239.82M192.17M235.05M184.59M191.08M149.03M134.96M134.6M64.81M39.77M17.1M
Discontinued Operations0000000000000000000-64.75M00
Minority Interest000000003.53B4.75M4.52M001.33M3.37M2.63M2.57M2.35M2.57M3.07M00
EPS (Diluted)3.473.132.853.411.881.911.571.561.451.341.281.090.850.970.780.810.630.580.570.121.01-0.02
EPS Growth %10.65%9.82%-16.42%81.38%-1.57%21.66%0.64%7.59%8.21%4.69%17.43%28.24%-12.37%24.36%-3.7%28.57%8.62%1.75%375%-88.12%4510.48%-
EPS (Basic)-3.182.883.461.921.971.621.601.481.361.301.110.871.000.800.830.650.590.590.281.01-0.02
Diluted Shares Outstanding169.63M176.65M180.44M185.14M188.09M192.96M195.78M195.16M193.98M197.05M210.13M219.15M225.17M235.75M229.53M226.35M224.84M220.07M218.44M202.67M39.24M68.84M
Basic Shares Outstanding167.92M173.89M178.39M182.35M184.18M187.8M190.4M190.07M190.67M193.86M206.86M216.61M220.85M229.35M223.7M221.57M219.31M215.5M213.48M199.52M39.24M68.84M
Dividend Payout Ratio-21.31%21.12%15.84%25.99%21.78%24.07%21.21%20.3%17.9%----271.75%--6.18%----

Key Metrics

Growth RegimeAccelerating
ProfitabilityStable
Balance SheetHealthy
Cash FlowStable
Top Statement Risk

AI cannibalization of legacy contracts

Verified Source

Metrics are mathematically derived from official filings.

SEC 10-K (2026Q2)

Accelerating Growth on AI Pivot

Revenue growth accelerated to 7.1% in Q2 2026, up from 6.6% a year earlier, driven by the ATS segment's 25% growth, as reported in the latest earnings release.

The sequential acceleration in revenue growth, from 6.6% in Q2 2025 to 7.1% in Q2 2026, suggests that the AI and Agentic Operations pivot is gaining commercial traction. The raised full-year guidance, with ATS revenue expected to grow at least 25%, indicates that this momentum is broadening beyond initial expectations. However, the sustainability of this pace into 2027 remains uncertain, given the macro IT spending environment and potential for client budget constraints.

Gross Margin Expansion Amid AI Shift

Gross margin improved to 36.5% in Q2 2026 from 35.9% a year earlier, as per financial statements, suggesting that AI-led services are not yet compressing pricing.

The 60 basis point year-over-year expansion in gross margin, from 35.9% to 36.5%, indicates that the company is managing to offset wage inflation and any potential pricing pressure from AI-driven efficiencies. This improvement, despite the risk of cannibalization of legacy F&A contracts, suggests that the mix shift toward higher-value digital services is accretive. Investors should monitor whether this margin stability persists as AI adoption scales, as the 35.6% gross margin in the prior year may have been a trough.

Operating Leverage Tempered by SG&A

Operating income grew 7.5% year-over-year in Q2 2026, while revenue grew 7.1%, indicating modest operating leverage, with SG&A up 10.4% as per reported figures.

The slight operating leverage, with operating income growth outpacing revenue growth by 40 basis points, is positive but muted by a 10.4% increase in SG&A expenses. This suggests that the company is reinvesting in sales and marketing to capture the AI opportunity, which may be necessary but could pressure margins if revenue growth decelerates. The operating margin of 14.4% in Q2 2026 is below the 16.1% seen in Q1 2026, indicating some quarterly volatility in cost management.

Earnings Quality Supported by SBC

Net income rose 9.8% year-over-year in Q2 2026, but stock-based compensation of $48.6M, as disclosed, represents 33% of net income, warranting scrutiny.

The quality of reported earnings is somewhat diluted by the significant stock-based compensation expense, which at $48.6 million in Q2 2026 is the highest in the provided quarters and represents a substantial portion of net income. This suggests that a meaningful part of the earnings growth is being delivered through equity compensation, which may not be sustainable if the stock price underperforms. Investors should adjust for SBC to assess the true cash earnings power, especially as the company pivots to AI and may need to attract top talent.

SG&A Rising as AI Investment Intensifies

SG&A expenses increased 10.4% year-over-year in Q2 2026, outpacing revenue growth, as per income statement data, indicating aggressive reinvestment in the AI pivot.

The 10.4% increase in SG&A, compared to 7.1% revenue growth, suggests that management is deliberately increasing spending on sales, marketing, and product development to support the Agentic Operations strategy. This is a deliberate trade-off to drive future growth, but it may compress near-term operating margins if revenue growth does not accelerate further. The absence of R&D line items in the data implies that such costs are embedded in SG&A, making it a critical line to monitor for efficiency.

AI Cannibalization Risk Looms

Despite gross margin expansion, the risk of AI-driven price reductions on legacy F&A contracts remains, as clients may demand lower prices for automated services, per industry trends.

The most significant challenge to the current narrative is the potential for AI to cannibalize legacy business process management contracts, as clients may expect cost savings from automation. While the ATS segment's 25% growth suggests new demand is offsetting any compression, the 36.5% gross margin in Q2 2026 is only modestly above the 35.9% a year earlier, indicating that any pricing pressure is being managed. However, if AI adoption accelerates, the company may face a structural decline in pricing power for its traditional services, which could erode margins over time. Investors should monitor the gross margin trajectory and the mix of revenue between legacy and AI-driven services.

G — Frequently Asked Questions

Quick answers to the most common questions about buying G stock.

What was Genpact Limited's (G) revenue in 2025?

For fiscal year 2025, Genpact Limited (G) reported total revenue of $5.08B. This represents a 932.7% increase compared to $491.9M in 2005.

Is Genpact Limited (G) profitable?

Genpact Limited (G) is profitable, generating $552.5M in net income for the fiscal year ending 2025 with a net profit margin of 10.9%.

What is Genpact Limited's operating profit margin?

Genpact Limited (G) reported an operating income of $760.0M, resulting in an operating profit margin of 15.0%. This margin reflects the operational efficiency of the business before interest and taxes.

What is Genpact Limited's gross profit and gross margin?

Genpact Limited (G) generated $1.81B in gross profit for the year, representing a gross profit margin of 35.6%. This demonstrates the company's core pricing power and production efficiency.